Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
PLEASANTON, Calif., Jan. 10, 2017 -- Title21 Health Solutions (www.Title21Health.com), a provider of easy-to-use and integrated software solutions to support health science organizations to improve efficiencies, compliance and patient safety is pleased to announce its selection as the enterprise quality management solution (EQMS) for Versiti. Versiti, whose affiliates include BloodCenter of Wisconsin™, Heartland Blood Centers™, Indiana Blood Center™, and Michigan Blood™, offers a comprehensive range of blood related services to help healthcare systems deliver high quality patient care.
“Versiti selected Title21 Health Solutions’ EQMS due to its robust, yet easy-to-use solutions with a very attractive ROI in the industry. It is critical that Versiti utilize an enterprise solution that supports our integration while delivering the highest efficiency and quality to maintain our competitive edge, and help us provide the highest value to our customers,” stated Meg McElligott, SBB (ASCP), chief quality officer of Versiti. “Title21 came highly recommended by two of our affiliates, Indiana Blood Center and Michigan Blood, who currently utilize Title21 and have experienced process improvements for document control and training, change management, error management, CAPA, equipment QC tracking and incident reporting.”
Title21’s EQMS is designed to facilitate quality across the enterprise while maintaining flexibility for each location’s site-specific processes. This enables multiple sites to operate on a common platform, while maintaining workflows and processes specific to their location. Permission controls ensure that each site has access to what they need while providing centralized data management, reporting and oversight at the enterprise-level. Data is highly accessible via iPads® and other tablets with robust security and 21 CFR Part 11 compliance.
“Versiti’s selection of Title21 is a testament to our ability to deliver high value and powerful functionality in today’s cost sensitive market. The scalability and breadth of our technology can support the long-term data management needs of Versiti’s service areas including transfusion medicine, transplantation, cellular therapies, hematology and oncology and genomics,” remarked Lynn Fischer, chief executive officer of Title21 Health Solutions. “We are aligned with Versiti’s mission to increase healthcare quality, improve patient outcomes and reduce costs.”
About Title21 Health Solutions
Title21 Health Solutions delivers easy-to-use, flexible and integrated technology to support health sciences organizations to gain efficiencies, improve compliance and heighten quality. Title21’s product line includes web-based quality management solutions and the most comprehensive cellular therapy software available on the market. Learn more about Title21 Health Solutions at www.Title21Health.com.
About Versiti
Versiti was formed with the mission to improve the health of patients and enable the success of our healthcare partners nationally. We provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases to meet the needs of each of our customers. The collective efforts of Versiti affiliates result in improved patient outcomes, expanded access to care and cost efficiencies for healthcare systems nationwide. For more information, visit www.versiti.org.
Contact: Haley Roebuck [email protected]
